Trial intelligence / Profile preview

Lianhuaqingwen as adjunctive therapy for acute exacerbation of chronic obstructive pulmonary disease

ChiCTR-TRC-13003240Phase 4Completed

Sponsor
Huashan Hospital
Start
Jan 2012
Countries
1
01

Overview

Phase 4, randomised trial of Lianhua Qingwen in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Huashan Hospital. Primary endpoints: COPD Assessment Test scale, Chinese Medicine Symptom Complex Score scale and 1 more. Started Jan 2012; status: completed.

02

Drugs

Lianhua Qingwen
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on ChiCTR-TRC-13003240.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-13003240.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call